FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2511529814> ?p ?o ?g. }

• W2511529814 endingPage "194" @default.
• W2511529814 startingPage "187" @default.
• W2511529814 abstract "Effective management of adverse events (AEs) following vandetanib treatment is important to maximize clinical benefits. We examined whether more frequent contact with vandetanib-treated patients reduced AEs of CTCAE grade 2 or higher.In this open-label, multicentre, phase III study, patients with locally advanced or metastatic medullary thyroid cancer were randomized to a patient outreach programme (outreach) or a standard AE monitoring schedule (vandetanib control) for 52 weeks. In addition to standard AE monitoring, patients in the outreach arm were contacted every 2 weeks by telephone/during their clinic visit for specific AE questioning related to diarrhoea, nausea, vomiting, fatigue, headache and rash. Patients received vandetanib at 200 or 300 mg/day, depending on the creatinine levels at screening.Altogether, 205 patients were randomized (outreach, n = 103; vandetanib control, n = 102). This study did not meet its primary objective; the mean percentage of time patients experienced at least one AE of grade 2 or higher was higher for the outreach group (51.65%) than for the vandetanib control group (45.19%); the difference was not statistically significant (t statistic: 1.29; 95% CI -3.44 to 16.37%; p = 0.199). The most frequently reported AEs were diarrhoea (56.9% for the outreach group vs. 46.6% for the vandetanib controls), hypertension (36.3 vs. 31.1%), rash (25.5 vs. 24.3%) and nausea (25.5% vs. 18.4%), and the most frequently reported AEs of grade 2 or higher were hypertension (33.3 vs. 23.3%), diarrhoea (26.5 vs. 24.3%) and dermatitis acneiform (11.8 vs. 9.7%).Additional outreach to patients treated with vandetanib had no impact on the rate or severity of AEs compared to the standard AE monitoring schedule. AEs were consistent with the known safety profile of vandetanib." @default.
• W2511529814 created "2016-09-16" @default.
• W2511529814 creator A5007399848 @default.
• W2511529814 creator A5014239599 @default.
• W2511529814 creator A5014472885 @default.
• W2511529814 creator A5027117186 @default.
• W2511529814 creator A5034097963 @default.
• W2511529814 creator A5043606695 @default.
• W2511529814 creator A5057277696 @default.
• W2511529814 creator A5072927466 @default.
• W2511529814 creator A5078402710 @default.
• W2511529814 creator A5086684261 @default.
• W2511529814 date "2016-01-01" @default.
• W2511529814 modified "2023-10-11" @default.
• W2511529814 title "Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer" @default.
• W2511529814 cites W1971197406 @default.
• W2511529814 cites W1972965892 @default.
• W2511529814 cites W1985630117 @default.
• W2511529814 cites W1989888312 @default.
• W2511529814 cites W2010141132 @default.
• W2511529814 cites W2031238707 @default.
• W2511529814 cites W2044761914 @default.
• W2511529814 cites W2050104081 @default.
• W2511529814 cites W2060543813 @default.
• W2511529814 cites W2062316437 @default.
• W2511529814 cites W2070767967 @default.
• W2511529814 cites W2073097715 @default.
• W2511529814 cites W2109833554 @default.
• W2511529814 cites W2111060860 @default.
• W2511529814 cites W2118559000 @default.
• W2511529814 cites W2119501407 @default.
• W2511529814 cites W2125212831 @default.
• W2511529814 cites W2125916043 @default.
• W2511529814 cites W2137709853 @default.
• W2511529814 cites W2139257964 @default.
• W2511529814 cites W2140822696 @default.
• W2511529814 cites W2147994473 @default.
• W2511529814 cites W2160445978 @default.
• W2511529814 cites W2160863198 @default.
• W2511529814 cites W2166494017 @default.
• W2511529814 cites W4292528167 @default.
• W2511529814 doi "https://doi.org/10.1159/000448919" @default.
• W2511529814 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5091223" @default.
• W2511529814 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27843809" @default.
• W2511529814 hasPublicationYear "2016" @default.
• W2511529814 type Work @default.
• W2511529814 sameAs 2511529814 @default.
• W2511529814 citedByCount "9" @default.
• W2511529814 countsByYear W25115298142017 @default.
• W2511529814 countsByYear W25115298142018 @default.
• W2511529814 countsByYear W25115298142019 @default.
• W2511529814 countsByYear W25115298142021 @default.
• W2511529814 countsByYear W25115298142022 @default.
• W2511529814 crossrefType "journal-article" @default.
• W2511529814 hasAuthorship W2511529814A5007399848 @default.
• W2511529814 hasAuthorship W2511529814A5014239599 @default.
• W2511529814 hasAuthorship W2511529814A5014472885 @default.
• W2511529814 hasAuthorship W2511529814A5027117186 @default.
• W2511529814 hasAuthorship W2511529814A5034097963 @default.
• W2511529814 hasAuthorship W2511529814A5043606695 @default.
• W2511529814 hasAuthorship W2511529814A5057277696 @default.
• W2511529814 hasAuthorship W2511529814A5072927466 @default.
• W2511529814 hasAuthorship W2511529814A5078402710 @default.
• W2511529814 hasAuthorship W2511529814A5086684261 @default.
• W2511529814 hasBestOaLocation W25115298141 @default.
• W2511529814 hasConcept C121608353 @default.
• W2511529814 hasConcept C126322002 @default.
• W2511529814 hasConcept C197934379 @default.
• W2511529814 hasConcept C2777170512 @default.
• W2511529814 hasConcept C2778019345 @default.
• W2511529814 hasConcept C2778570526 @default.
• W2511529814 hasConcept C2778695046 @default.
• W2511529814 hasConcept C2779761222 @default.
• W2511529814 hasConcept C2780120053 @default.
• W2511529814 hasConcept C2780333294 @default.
• W2511529814 hasConcept C2780580376 @default.
• W2511529814 hasConcept C71924100 @default.
• W2511529814 hasConceptScore W2511529814C121608353 @default.
• W2511529814 hasConceptScore W2511529814C126322002 @default.
• W2511529814 hasConceptScore W2511529814C197934379 @default.
• W2511529814 hasConceptScore W2511529814C2777170512 @default.
• W2511529814 hasConceptScore W2511529814C2778019345 @default.
• W2511529814 hasConceptScore W2511529814C2778570526 @default.
• W2511529814 hasConceptScore W2511529814C2778695046 @default.
• W2511529814 hasConceptScore W2511529814C2779761222 @default.
• W2511529814 hasConceptScore W2511529814C2780120053 @default.
• W2511529814 hasConceptScore W2511529814C2780333294 @default.
• W2511529814 hasConceptScore W2511529814C2780580376 @default.
• W2511529814 hasConceptScore W2511529814C71924100 @default.
• W2511529814 hasIssue "3" @default.
• W2511529814 hasLocation W25115298141 @default.
• W2511529814 hasLocation W25115298142 @default.
• W2511529814 hasLocation W25115298143 @default.
• W2511529814 hasLocation W25115298144 @default.
• W2511529814 hasLocation W25115298145 @default.
• W2511529814 hasOpenAccess W2511529814 @default.
• W2511529814 hasPrimaryLocation W25115298141 @default.
• W2511529814 hasRelatedWork W2049084651 @default.

• next